SAN ANTONIO — As the GLP-1 class has taken over in recent years, a once-fringe conference has come into the spotlight for the biopharma industry.
News
- At this year's ObesityWeek, GLP-1s aren't the only talk of the town - Endpoints News
- Scilex Holding Company filed SEC Form 8-K: Regulation FD Disclosure - Quantisnow
Identification No.) 960 San Antonio Road , Palo Alto , California , 94303. (Address of principal executive offices, including zip code).
- Demand for San Antonio flights hits record pace - The Business Journals
Demand for San Antonio flights hits record pace. Heightened traffic has underscored the need to advance the city's $2.5 billion airport expansion plan ...
- 'We're good' on weight loss: Biopharmas turn to muscle with new obesity drugs
SAN ANTONIO — It took decades to get to the GLP-1 breakthrough in obesity treatment. Now, the biopharma industry is clamoring over the field's ...
- SolasCure and U.S. Army Institute of Surgical Research Collaborate for Combat Wound Care
CAMBRIDGE, England & SAN ANTONIO--(BUSINESS WIRE)--SOLASCURE Ltd (“SolasCure”), a biotechnology company developing a novel treatment to transform ...